This morning Deutsche Bank published a report stating, "Valeant agreed to acquire Dermik - the North American dermatology subsidiary of Sanofi as well as worldwide (ex-France) rights to facial aesthetic product Sculptra (estimated US sales of $32M) - for approximately $425M."
Valeant VRX closed Friday at $53.34. Dermik SNY closed Friday at $39.77.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
